Citations for
1FBXO38, FGL1
FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation.
Tian T, Xie X, Yi W, Zhou Y, Xu Y, Wang Z, Zhang J, Lin M, Zhang R, Lv Z, Li X, Lv L, Xu Y.
Cell Rep. Nov 28;42(11):113362. doi: 10.1016/j.celrep.2023.113362. Epub 2023 Nov 7. 2023
2AP3B2, FBXO38
Two-stage comprehensive evaluation of genetic susceptibility of common variants in FBXO38, AP3B2 and WHAMM to severe chronic periodontitis.
Shang D, Dong L, Zeng L, Yang R, Xu J, Wu Y, Xu R, Tao H, Zhang N.
Sci Rep 5:17882. doi: 10.1038/srep17882. 2015
3DSMACW, FBXO38
A Dominant Mutation in FBXO38 Causes Distal Spinal Muscular Atrophy with Calf Predominance.
Sumner CJ, d'Ydewalle C, Wooley J, Fawcett KA, Hernandez D, Gardiner AR, Kalmar B, Baloh RH, Gonzalez M, Züchner S, Stanescu HC, Kleta R, Mankodi A, Cornblath DR, Boylan KB, Reilly MM, Greensmith L, Singleton AB, Harms MB, Rossor AM, Houlden H.
Am J Hum Genet 93(5):976-83. doi: 10.1016/j.ajhg.2013.10.006. Epub 2013 Oct 24. 2013
4FBXO38, KLF7
Identification of MoKA, a novel F-box protein that modulates Kruppel-like transcription factor 7 activity.
Smaldone S, Laub F, Else C, Dragomir C, Ramirez F.
Mol Cell Biol 24(3):1058-69. 2004